Adjustable Continence Therapy (ProACT™) from Uromedica, Inc., is a minimally invasive urological implant designed to treat male patients who have stress urinary incontinence arising from intrinsic sphincter deficiency following radical prostatectomy for prostate cancer or transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH). ProACT Therapy offers an effective first-line treatment option for post-prostatectomy incontinence before invasive surgical consideration or implant of an Artificial Urinary Sphincter (A.U.S.) or adjustable sling. Median time to regain continence after radical prostatectomy is ~3 months;4 if a patient still leaks after six months, it is worthwhile to consider ProACT Therapy.
Languages
English
Ελληνικά
